NASDAQ: NVCT - Nuvectis Pharma, Inc.

Lønnsomhet i seks måneder: +53.42%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Nuvectis Pharma, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Nuvectis Pharma, Inc.

Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. The company develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate that inhibits the Proto-oncogene c-Src and YES1 kinases. It has license agreement with the CRT Pioneer Fund for the NXP800 and any of related derivatives; and the University of Edinburgh for the NXP900 and any of associated derivatives.

flere detaljer
The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2022-02-04
ISIN US67080T1088
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.nuvectis.com
Цена ао 8.75
Prisendring per dag: 0% (9.65)
Prisendring per uke: -5.39% (10.2)
Prisendring per måned: +40.67% (6.86)
Prisendring over 3 måneder: +84.87% (5.22)
Prisendring over seks måneder: +53.42% (6.29)
Prisendring per år: +17.68% (8.2)
Prisendring over 3 år: +28.67% (7.5)
Prisendring siden begynnelsen av året: +78.37% (5.41)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 622.09 1
P/BV 9.53 1
P/E 0 0
EV/EBITDA -4.8 0
Total: 2.63

Effektivitet

Navn Betydning Karakter
ROA, % -100.55 0
ROE, % -173.41 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA 0 10
Total: 9.8

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 0 0
Lønnsomhet Ebitda, % 228870 10
Lønnsomhet EPS, % 141153.95 10
Total: 6
Flere detaljer

Institusjoner Volum Dele, %
Blackrock Inc. 387891 2.18
Vanguard Group Inc 294283 1.66
Baldwin Brothers, Inc. 142040 0.8
Geode Capital Management, LLC 131657 0.74
State Street Corporation 118279 0.67
Northern Trust Corporation 61574 0.35
Renaissance Technologies, LLC 51800 0.29
Millennium Management LLC 34011 0.19
Forbes, J.M. & Company 34000 0.19
GSA Capital Partners LLP 27313 0.15

ETFDele, %Lønnsomhet for året, %Utbytte, %
iShares Micro-Cap ETF 0.0153 17.09 1.54048
0.0217.091.54



Veileder Stillingstittel Betaling Fødselsår
Mr. Ron Bentsur M.B.A. Co-Founder, Chairman, CEO & President 1.12M 1966 (59 år)
Dr. Enrique Poradosu Ph.D. Co-Founder, Executive VP, Chief Scientific & Business Officer 705.5k 1967 (58 år)
Mr. Shay Shemesh Co-Founder, Executive VP, Chief Development & Operations Officer 705.5k 1984 (41 år)
Mr. Michael Carson CPA Vice President of Finance N/A 1976 (49 år)

Adresse: United States, Fort Lee. NJ, 1 Bridge Plaza - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.nuvectis.com